A novel human herpesvirus, now named human herpesvirus 6 (HHV-6), has been isolated from patients with lymphocytic disorders independently by several groups of investigators (2, 5, 10, 18, 21) . HHV-6 is an enveloped virus (diameter, about 200 nm) with an electron-dense icosahedral core composed of 162 capsomers containing a large doublestranded DNA genome (5, 7, 18) . This virus was initially named human B lymphotropic virus, because it infected B lymphocytes (18) . However, later it was found mainly to infect and replicate in lymphocytes of the T-cell lineage (1, 11, 12, 20) . Preliminary characterization of HHV-6 indicated that it was antigenically and genetically distinct from other human herpesviruses (cytomegalovirus [CMV] , herpes simplex virus types 1 and 2 [HSV-1 and HSV-2, respectively], varicella-zoster virus [VZV] , and Epstein-Barr virus [EBV] [7, 10, 18] ). However, Efstathiou and colleagues (6) have recently reported that the HHV-6 genome shows sequence homology to that of human CMV. Most children have antibodies against this virus by the time they are 2 years old (15) , but it is not known whether HHV-6 causes disease in humans. We recently discovered that HHV-6 is a causal agent of exanthem subitum (22) . An immunofluorescence test is usually used for the diagnosis of HHV-6 infection in serum, but this method takes at least 1 week, because serum should be collected during the convalescent phase of the disease.
A novel technique, the polymerase chain reaction (PCR), was recently developed for the amplification of DNA or RNA in vitro, and this technique can be used for many purposes, such as analysis of inherited disorders and the detection of somatic diseases (14, 16, 17) . One of the most important applications of this method, which gives results in a short time, has been for the detection of infectious agents that are present in small numbers in clinical samples (4, 19) . Recently, Buchbinder and associates (3) reported that PCR * Corresponding author.
could be used to detect HHV-6 DNA in peripheral blood cells of patients with the acquired immune deficiency syndrome (AIDS) and various lymphoproliferative disorders. We report here the use of PCR for detecting HHV-6 in peripheral blood mononuclear cells of patients with exanthem subitum.
MATERIALS AND METHODS
Cells and viruses. Umbilical cord blood mononuclear cells were cultured at 37°C in RPMI 1640 medium supplemented with 10% fetal bovine serum, L-glutamine, penicillin, kanamycin, 0.1 U of recombinant human interleukin-2 (kindly supplied by Takeda Chemical Industries) per ml, and 5 1tg of phytohemagglutinin (Honen Oil Co.) per ml. Umbilical cord blood lymphocytes were infected with HHV-6 (Hashimoto strain), which was isolated in our laboratory from a patient with exanthem subitum, and were cultured as described previously (22) . When cytopathic effects were observed, approximately 1 to 2 weeks after infection, the cells were collected by centrifugation and infected cells were disrupted by sonication. The supernatant that was obtained by centrifugation (K-80H; Kubota) at 3,000 rpm at 4°C was stored at -80°C until use. The Kawaguchi strain of VZV, the AD 169 strain of human CMV, and the Seibert and UW268 strains of HSV-1 and HSV-2, respectively, were used for these studies. Human embryonic fibroblast cells, which were passaged 10 to 15 times, were cultured in a mixture of Eagle minimal essential medium and medium 199 containing 10% fetal bovine serum for growth, and 3% fetal bovine serum for maintenance. Human embryonic fibroblast cells were infected with each virus and cultured for certain periods of time. When infected cells showed a cytopathic effect, they were harvested and their DNAs were extracted as described below. A cell line producing EBV (B95-8 cell line) was also propagated, and its DNA was extracted in the same fashion. The titer of HHV-6 was determined on MT-4 cells (13) 10 min and then subjected to 30 amplification cycles. Annealing was performed at 62°C for 2 min, extension was performed at 72°C for 5 min, and denaturation was performed at 90°C for 1 min. The primers were used at a concentration of 1.0 ,uM each. The amplification reaction was carried out in a DNA thermal cycler (Perkin-Elmer/ Cetus). The primers of X phage DNA (Perkin-Elmer/Cetus) and 3-globin (16) were also used as positive controls in samples in which the amplification of viral DNA was not observed. The conditions of PCR were the same as those described above, except that the annealing temperature was 550C.
Detection of amplified product. The amplified product was detected by direct gel analysis and a dot blot hybridization assay by using cloned DNA probe (part of the Salt fragment of DNA described above).
For direct gel analysis, 10 ,ul of the reaction mixture was subjected to electrophoresis on a 1.5% agarose gel, and DNA was located by UV fluorescence after staining with ethidium bromide. Molecular weight markers were included in each gel.
A band of 776 base pairs was seen when samples were amplified. For dot blot analysis, 10 
RESULTS
Amplification of different HHV-6 strains. The ability of our primers to detect eight different clinical isolates (six samples isolated from patients with exanthem subitum in Japan, one sample isolated from a patient in Japan who had a renal transplant, and one sample isolated from a patient with AIDS in the United States) was evaluated. Samples of 0.05 to 0.2 ,ug of DNA from infected cells were used as templates in the PCR. All strains gave a positive band on direct gel electrophoresis (Fig. 1, lanes 1 through 8) .
Specificity of PCR. The specificity of the PCR and the primers for HHV-6 were evaluated by using five other human herpesviruses, HSV-1, HSV-2, VZV, CMV, and EBV. DNAs from cells infected with these viruses were extracted and purified as described above, and samples of 0.01 to 1 ,ug of DNA were used as templates in the PCR. No amplification was detected by direct gel electrophoresis (Fig.  1) or Southern blot hybridization (data not shown). Because samples might have been contaminated with inhibitors, DNA samples of approximately 1 ,ug containing 1 ng of phage DNA were used as templates, and the PCR was performed in accordance with the instructions provided with the GeneAmp DNA amplification kit (Perkin-Elmer/Cetus). A positive band was observed on direct gel electrophoresis (Fig. 1, lane A) . Next, P-globin DNA in all samples except EBV were also amplified by using primers, as described by Saiki et al. (16) . A band with a molecular weight of 150 was observed (Fig. 1, lane B) .
Sensitivity of PCR. For determination of the sensitivity of PCR in this system, a viral sample with an infectivity titer of 105.0 TCID.5d/ml was diluted to 10-9 and assayed by PCR. A sample of 10 ,ul of virus equivalent to 10-1 TCID50 was detectable by direct gel analysis (Fig. 2) , while a sample equivalent to 10-4 TCID50 could be detected by dot blot hybridization (Fig. 3) .
Detection of HHV-6 DNA in peripheral blood mononuclear cells of patients with exanthem subitum. Blood samples were collected from eight patients diagnosed clinically as having exanthem subitum, and HHV-6 DNA in their mononuclear cells was examined by PCR. Mononuclear cells from umbilical cord blood were used as controls. Seven samples were obtained from different patients during the acute phase (four samples during the febrile period and three samples during 10 Antibody response to HHV-6. Seven paired serum samples (acute-and convalescent-phases samples 1 through 6 and 8) and one serum specimen obtained from a patient in the acute phase of the disease (sample from patient 7) were tested for antibody to HHV-6 by the immunofluorescence technique (Table 1) . No antibody was detected (a titer of less than 1:10) in sera obtained from patients in the febrile and exanthem phases of disease (samples from patients 1 through 5, 7, and 8). The antibody titer of the sample from patient 6 was 1:160, because the sample was obtained 1 week after disappearance of the rash. The antibody titers of six paired serum samples showed that the antibody titer became positive in the con- valescent phase, but the antibody titer of the serum from patient 8 was still <1:10 during the convalescent phase (Table 1) . Twenty-six serum samples, including those used for PCR, obtained from patients with exanthem subitum during the acute and convalescent phases were assayed for IgM antibody. As shown in Fig. 5 , IgM antibodies were not detected in the sera during the acute phase, which lasted until day 4 of onset of disease, but it was detected on day 7 and persisted for 3 weeks, but it was not detectable in most sera 1 month after the onset of disease.
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DISCUSSION
In this study we found that PCR could be used for the detection of HHV-6. The sequence of HHV-6 DNA is not yet available, so we used primers corresponding to the partial sequence of a cloned DNA fragment. There are reports that there is no cross-reaction at the DNA level between HHV-6 DNA and the DNAs of five other human herpesviruses (7, 10) , although cross-hybridization of a HHV-6 DNA fragment and a CMV DNA fragment has been observed (6) . As shown in Fig. 1 , the primers used in our experiment were specific for HHV-6, showing no detectable amplification of five other human herpesviruses. PCR amplified DNA sequences of six other HHV-6 strains isolated from patients with exanthem subitum in different regions of Japan, from a patient who had a renal transplant, and from a patient with AIDS in the United States. Our rate of virus t-80- isolation from patients with clinically diagnosed exanthem subitum during the acute phase of infection was approximately 67% (data not shown). As shown in Fig. 3 , PCR detected HHV-6 DNA equivalent to 10-1 TCID50 by gel electrophoresis and equivalent to 10-4 TCID50 by dot blot analysis. By this assay, no HHV-6 DNA was detected in mononuclear cells of umbilical cord blood (data not shown). From these data, PCR was concluded to be sufficiently sensitive for the diagnosis of HHV-6 infection. As shown in Fig. 4 , in all patients with exanthem subitum in which HHV-6 infection was detected by the antibody test, HHV-6 DNA was detectable, even when the samples were collected during the convalescent phase of the disease. However, the amount of viral DNA in the blood was less during the convalescent phase than during the acute phase. These data suggest that during the convalescent phase, the viral DNA is present in the peripheral blood cells, although antibody was detected at high levels and we were unable to isolate the virus from patients during the convalescent phase. (9) . Therefore, it is important to distinguish this disease. Patient 8 was diagnosed as having exanthem subitum because febrile and exanthem phases were recognized, but no DNA was detected in blood samples from the patient and no increase in antibody against HHV-6 was detected by the immunofluorescence test. Therefore, this patient may have been infected with another virus. IgM antibody was first detected in patients on day 5, and it persisted for 2 weeks (Fig. 5) . On the other hand, IgG antibody was first detected on day 7 of disease and reached a maximum in 2 to 3 weeks (22) . These data on the antibody response suggest that HHV-6 causes a typical acute viral infection.
The PCR assay is sensitive and specific and takes only 1 to 2 days to perform. The application of PCR for the detection of HHV-6 should be very useful, particularly when a drug for the treatment of HHV-6 infection has been developed, such as acyclovir and ganciclovir, which are available for the treatment of HSV, VZV, and CMV infections.
